[Responses of medical imaging in battered children. The Silverman-Ambroise Tardieu syndrome].

J Radiol

Hôpital d'Enfants Armand-Trousseau, Paris.

Published: November 1994

Imaging procedures offer an important contribution to the syndrome of the abused child that F.N. Silverman himself proposes to call the Ambroise Tardieu syndrome. First they disclose and analyse the lesions which may involve bones, encephalon or spinal cord, viscera, soft tissues. Then they must answer four questions: Traumatic lesion or normal variant? If traumatic, are there arguments pointing to abuse, for instance multiple bone lesions of different ages and more specifically fractures of ribs, clavicle, spine, pelvis, phalanxes? Is there a possibility of a general disease explaining such traumatic lesions? Etiologies are revised including sensibility deficits. Finally are the bad treatments inflicted with an intention of hurting, injuring or destroying? The answer results of a discussion with clinicians and social interveners but some lesions, as phalanx fractures, may be determining. In this situation that involves the vital prognosis and may induce severe sequellae the imaging strategy, fully described, is of paramount importance.

Download full-text PDF

Source

Publication Analysis

Top Keywords

[responses medical
4
medical imaging
4
imaging battered
4
battered children
4
children silverman-ambroise
4
silverman-ambroise tardieu
4
tardieu syndrome]
4
syndrome] imaging
4
imaging procedures
4
procedures offer
4

Similar Publications

Pulmonary arterial hypertension (PAH) is a syndrome characterized by increased pulmonary vascular resistance and elevated pulmonary artery pressure, ultimately leading to right heart failure and even death. Increasing evidence implicates the fat mass and obesity-associated protein (FTO) in various metabolic and inflammatory pathways; however, its role in pulmonary endothelial function and PAH remains largely unexplored. In this study, we examined the effects of endothelial cell-specific FTO knockout on PAH development.

View Article and Find Full Text PDF

Purpose: Immune checkpoint inhibitors (ICIs) are now first-line therapy for most patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC), and cetuximab is most often used as subsequent therapy. However, data describing cetuximab efficacy in the post-ICI setting are limited.

Methods: We performed a single-institution retrospective analysis of patients with R/M HNSCC treated with cetuximab, either as monotherapy or in combination with chemotherapy, after receiving an ICI.

View Article and Find Full Text PDF

Purpose: MAP2K1/MEK1 mutations are potentially actionable drivers in cancer. MAP2K1 mutations have been functionally classified into three groups according to their dependency on upstream RAS/RAF signaling. However, the clinical efficacy of mitogen-activated protein kinase (MAPK) pathway inhibitors (MAPKi) for MAP2K1-mutant tumors is not well defined.

View Article and Find Full Text PDF

In thrombosis and hemostasis, the formation of a platelet-fibrin thrombus or clot is a highly controlled process that varies, depending on the pathological context. Major signaling pathways in platelets are well established. However, studies with genetically modified mice have identified the contribution of hundreds of additional platelet-expressed proteins in arterial thrombus formation and bleeding.

View Article and Find Full Text PDF

Larotrectinib is a highly selective tropomyosin receptor kinase (TRK) inhibitor with efficacy in children with TRK fusion tumors. We evaluated patient outcomes after elective discontinuation of larotrectinib in the absence of disease progression in a protocol-defined wait-and-see subset analysis of eligible patients where treatment resumption with larotrectinib was allowed if disease progressed. We also assessed the safety and efficacy of larotrectinib in all pediatric patients with sarcoma.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!